In the xenograft mouse model established by SUP-T1 cells with moderate CD5 expression, after infusion of 2 × 106 CAR+ T cells per mouse, H65 and FHVH3 CAR-T cells temporarily inhibited and controlled cancer progression but failed to eradicate neoplastic cells (Figures 7A and 7B). This evidence concerns the gene CD5 and cancer.